quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·30d
PRRelease
Co-Diagnostics Inc. logo

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

CODX· Co-Diagnostics Inc.
Health Care
Original source

Companies

  • CODX
    Co-Diagnostics Inc.
    Health Care

Recent analyst ratings

  • Aug 12UpdateSidoti$5.00
  • Dec 29UpdateSidoti$14.00
  • Nov 12UpdateHC Wainwright & Co.$15.00

Related

  • PR7d
    Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
  • PR9d
    Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
  • PR14d
    Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
  • PR21d
    Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
  • SEC23d
    SEC Form 10-K filed by Co-Diagnostics Inc.
  • SEC23d
    Co-Diagnostics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR23d
    Co-Diagnostics Reports Full Year 2025 Financial Results
  • PR35d
    Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022